Transferring biobank research data between the EU and African countries
Despite the fact that the European General Data Protection Regulation (GDPR) provides ways to transfer data, it is difficult to find ways to share data between Europe and Africa. The feasible routes rely on EU enforcement. This means the possibilities for oversight are limited, leading to considerable data privacy risks.
According to a group of ethicists and legal scholars in the B3Africa project, it is vital that European researchers collaborate with biobank researchers in low and middle-income countries. This means we need to put procedures in place to enable data transfer from EU Member States to states in Africa. In a recent publication in the journal International Data Privacy Law, they write that in order to ensure effective data protection for data subjects in biobanking, the bar for data protection needs to be raised in the countries that receive data.
They write that although Kenya, Nigeria, South Africa, and Uganda have taken considerable steps towards developing data protection frameworks, it is only in South Africa and Nigeria that bills to protect personal information are likely to meet the level of protection that the GDPR sets out for biobank research. According to Santa Slokenberga and co-authors, the current legislative initiatives in Kenya and Uganda needs revision to ensure that privacy is protected when researchers share their data.
The article is open-access published, which means you can access it and read the full text on the journal website: EU data transfer rules and African legal realities: is data exchange for biobank research realistic?
By Josepine Fernow
More news from CRB
One in three underestimate their risk of heart infarction
One in three underestimate their own risk of cardiovascular disease. Many are good at understanding risks and risk factors when they pertain to other people. A recent study reveals that when it comes to our own risk, many of us appear to have a blind spot. In an interview, Åsa Grauman reveals how this finding could help improve risk communication in health care.
Looking for new preference studies postdoc!
We are looking for a postdoc researcher to work on an international project looking at parents' and health care professionals' preferences for screening and genetic testing for rare diseases in newborn children. And for attempting to identify patients by looking at the symptoms listed in their medical records using an algorithm. How this information is perceived will be explored using an instrument to measure Empowerment. Application deadline 12 July 2021!
Do educational tools influence what patients prefer?
Stakeholders across the medical product life cycle are eager to find out what patients prefer. From the pharmaceutical companies that develop new treatments, to the authorities that decide if they should become available to patients, and at what price. But to be useful in decision-making, the patient preferences collected need to be informed. A recent Patient Education and Counseling publication explores the use of educational tools in patient preference studies, and finds that sometimes, they influence patients’ preferences.
Fighting antibiotic resistance: We can do better!
In the shadow of the corona pandemic lurks the next global health crisis. Antibiotic resistance is one of the biggest threats to global health, food security, and development today and can affect anyone, of any age, in any country. Although antibiotic resistance is something that can happen regardless of what we do, unnecessary use of antibiotics is speeding up the process. On March 15, Mirko Ancillotti will defend his thesis. His research is an in-depth look at why we use antibiotics responsibly, why we sometimes do not, and what encourages us to do better.
Launch of EU Research Project “ENLIGHTENme”: Exploring the Impact of Urban Lighting on Health and Wellbeing
An interdisciplinary consortium of 22 partners will perform in-depth studies in three European cities to develop innovative, evidence-based policies to improve citizens’ quality of life addressing indoor and outdoor lighting. Our Deborah Mascalzoni will contribute her expertise in research ethics and bioethics.
Are you our new Professor of Medical Ethics?
Medical ethics is an interdisciplinary subject of research and education that critically, analytically and empirically studies the ethical and moral aspects of biomedical research and clinical practice. Speak Swedish well enough to teach? We are looking for a new Professor of Medical Ethics to strenghten our clincal research profile. Application deadline 31 March 2020!
Neurotwin: New European project proposes a novel therapy for Alzheimer’s disease
Neurotwin is a new 48-month EIC Pathfinder project initiated in January 2021 that will develop hybrid brain models able to represent the effects of non-invasive electrical brain stimulation appropriate in the context of large-scale connectivity alterations and oscillatory deficits that are characteristic to some of the brain disorders, such as Alzheimer’s disease. Uppsala University’s Centre for Research Ethics & Bioethics (CRB) leads the ethics and philosophy component of the project.
No data, no policy: New project promotes gender equality action in seven European research institutions
A new European research project prepares the ground for structural changes to promote gender equality in public and private research organisations. Led by the University of Turin, the four-year MINDtheGEPs project will identify good practice and help shape measures to reduce gender imbalances in seven research institutions and generate data to support the development of national and European policy for gender equality in research performing organisations. Uppsala University’s Centre for Research Ethics & Bioethics (CRB) contributes communications expertise, working together with Elsevier to support impact through communications and dissemination strategies for the project.
Season's Greetings from CRB
2020 was not what we expected. We are happy to have contributed expertise and skill to inform the discussion on vaccines and ethical guidance for intensive care. Now we look forward to new projects, new publications, new collaborations and a happy new 2021!! Want to stay connected? Follow our work on the Ethics Blog!
Pandemic – decision-making, communication & vaccination: See you at Smer’s ethics day 2020!
Ethical dilemmas are part of preparing for pandemics, and part of fighting contagion. The Swedish National Council on Medical Ethic’s (Smer) Ethics Day 2020 will consist of three webinars, all focusing on pandemics. Our Jessica Nihlén Fahlquist will participate in a panel discussion on vaccines against Covid-19.
Ethical, social and psychological impacts of genomic risk communication
Biomedical research is constantly finding new ways to detect genetic variation and link the findings to diseases and to the effects of various drug treatments. The amount of information that it produces keeps increasing, but we are still not sure how to manage it. Researchers who took part in the six-year Mind the Risk project coordinated from the Centre for Research Ethics & Bioethics have published their findings in an anthology focussed on genetic risk communication.
Academic integrity series for European Academic Integrity Week
We are hosting four lunch webinars in association with European Network for Academic Integrity during European Academic Integrity Week, 19-23 October. One for each day of the week except Wednesday the 21st, Global Ethics Day, when we are encouraging everyone to organise events at their home organisations.
New way to tailor treatment of acute myologic leukaemia
Using biomedical analyses, a new algorithm and integrating patient preferences, researchers in Italy, Spain, France, Germany, Finland, and Sweden will spend 3 years developing new treatments for acute myologic leukaemia, a cancer type of cancer where personalised treatment has not previously been available.
Culturally shaping developing minds
Are we socially steering evolution by influencing the cultural imprints to be stored in our brains? Recent neuroscientific findings would say so. In a recent paper, Kathinka Evers discusses the potential of being ‘epigenetically proactive’ and adapting our social structures to benefit brain development.
Space, time: bridging the epistemic gap of brain & mind
How do we become ourselves? How does neuronal activity turn into consciousness and the self? One of nature’s great scientific mysteries is the ‘common currency’ of brain and mind. Georg Northoff, Soren Wainio-Theberge and Kathinka Evers suggest looking for a ‘Spatiotemporal Neuroscience’ to dissolve the brain-mind puzzle.
Corona vaccine(s) should not be a race to the finish line
A brand new virus, the first pandemic in modern time, and in January or February 2021, we are expecting vaccine approvals. It has been a year, but is that enough? What might the consequences be of this race to the finish line? Jessica Nihlén Fahlquist, associate professor and lecturer at Uppsala University’s Centre for Research Ethics & Bioethics, spoke to Radio Sweden and raised her concerns about a race to the finish line.
Genomic data sharing requires public trust
Genomics research relies on the ability for clinicians, and researchers to share genetic data with each other across the world. The largest ever survey on global public attitudes towards genomic research and data sharing was just published in American Journal of Human Genetics. Lack of trust in who data is shared with could significantly hinder genomic research. With less than half of the respondents saying they would be happy for their genetic information to be shared for more than one purpose, the results send a call to action for the genomic research community to build public trust.
Russian vaccine development raises important questions about transparency and trust
The Russian Covid-19 vaccine and the lack of transparency of the research about it could have a negative impact on the public’s perception of vaccines, and their trust in government authorities. But it also raises other important questions, such as how we should deal with research from less democratic countries?
Working and living during the Covid-19 crisis: recommendations from the Human Brain Project
The Covid-19 pandemic has changed the wat we work and live, moving much of it online. But how do we make sure that digital works is successful, and becomes a valuable experience? In a recent issue of the Journal of Responsible Technology, the Human Brain Project’s Karin Grasenick and Manuel Guerrero writes about responsible research and innovation and digital inclusiveness during the Covid-19 crisis and the I-Include initiative.
Ethical choices in a pandemic
During the coronavirus pandemic, many ethical questions come to the fore. How should care services prioritise among severely ill patients? And how far should the rights of individuals be restricted? There are various ethical perspectives, think Anna T Höglund and Jessica Nihlén Fahlquist, researchers at the Centre for Research Ethics and Bioethics (CRB) in Uppsala.
Cancer treatment no better in clinical trials
Many belive cancer patients who take part in clinical trials receive better treatment than others. A recent study from researchers at Uppsala University, published in BMC Cancer, pokes a hole in that theory. The authors, concluding that there is no quality evidence to support the idea that patients who participate in clinical trials have better outcomes.
What demands can we place on physicians during the COVID-crisis?
Physicians have a responsibility to protect patients’ autonomy, do no harm, to do good and to divide resources fairly. But how these ethical principles are interpreted in practice can differ from physician to physicians. For whom are they supposed to do good, for example? For the patient, a patient group or society as a whole? With limited resources and large demand, these questions are more crucial than ever. And different interpretation can create conflict.
Research podcast on ethical crossroads in a pandemic
The corona pandemic brings a lot of ethical issues to the fore. For example about priorities in the health care system, or limiting individual's rights to protect those that are vulnerable. Episode 47 of Uppsala University’s' "Forskarpodden" talks about public health ethics with CRB's Anna T. Höglund and Jessica Nihlén Fahlquist (in Swedish).
What should we eat? An ethical framework for well-grounded food choices
Being an ethically aware consumer today is difficult. Partly because there are so many aspects to take into account, and partly because it is difficult to find trustworthy and reliable information to base your food choices on. But that does not mean there is no point in thinking about what could constitute an ethical choice of food. Anna T. Höglund explores ethical food choices in a recent publication.
Swedish obstetric routines changed after criticized study: Too soon?
Decisions to induce prolonged pregnancies in week 41 instead of 42 were made in two Swedish healthcare regions as a result of the Swepis study. Now, the study is facing criticism. External researchers are critical to conclusions drawn by the authors and that clinical routines have changed before the study has been reviewed in its entirety.
Governance and ethics of health care in focus
Governance and ethics was the theme at the Swedish National Council on Medical Ethics' Ethics Day 2019. Among the presenters was Anna T. Höglund, associate professor of ethics at the Centre for Research Ethics & Bioethics at Uppsala University. Together with Erika Falkenström, she presented on the subject of "Ethics in policy and governance: What ethical competence do health care decision-makers need?".
Connecting the brain and consciousness
What is consciousness? What does it mean to be ‘aware’, and how is our consciousness connected to the physical brain? A recent thesis from Uppsala University explores the philosophical aspects of the issue, and proposes a solution: the ‘intrinsic consciousness’ theory.
Egg donation for gene editing in embryos expose women to health risks
Current gene editing approaches allow for precise modification of DNA. These could potentially be used to correct disease-causing genes in human embryos.To evaluate the safety and efficacy of this approach, a large number of studies would be needed. To create embryos for this purpose, women have to donate eggs. In a recent Nature correspondence, CRB’s Emilia Niemiec and Heidi Howard draw attention to the health risks associated with egg donation in this context.
Choosing what's for dinner raises ethical questions
Anna T Höglund, associate professor at CRB, recently wrote a book on food ethics. These past few days, she has been visible in Swedish news coverage. Trying to answer the question of "What's for dinner?" is not always as easy as we would like it to be. Our choice of food impacts the environment, animal welfare and our health.
Cheating students: Swedish university teachers sometimes naïve
Swedish television have reported on a survey that shows Swedish students use commercial ghost writing services to a lesser extent than students in other countries. However, this might change as the number of courses offered in English are increasing. According to Sonja Bjelobaba, researcher at Uppsala University and associated to the Centre for Research Ethics & Bioethics (CRB), sometimes, Swedish teachers are naïve about these issues.
Future ethical standards for ICT, Big Data, AI and robotics
Policymakers struggle to assess the ethical, legal and human rights impacts of IT systems in research, industry, and at home. At the same time, research needs to be useful for industry, academia, and society to have impact on policy. The PANELFIT, SHERPA and SIENNA projects just published an editorial in Orbit to explain the projects collaborate and work together with stakeholders to improve ethical, human rights and legal frameworks for information and communication technologies (ICT), big data analytics, artificial intelligence (AI) and robotics.
First European biobank for research on breast milk and medicines
A new large European research project will fill the knowledge gaps when it comes to medical treatments of pregnant and nursing women. To be able to evaluate the effects of drugs during pregnancy and breast feeding, Uppsala biobank will collect and store breast milk and blood samples form pregnant and nursing women currently under medical treatment. The samples will be collected from women around Europe. In addition, the drug analysis platform UDOPP at the SciLifeLab’s Uppsala site will develop methods and technology to analyze drug residues in milk and blood.
Testing for hereditary (genetic) diseases before pregnancy raises ethical issues
Screening all or most couples for genetic disease before pregnancy could provide more options for couples who want to have children. But this would also threaten the core values of the Swedish health care system. Amal Matar gave an interview on the ethics of genetic screening before pregnancy, the subject of her dissertation, in Dagens Nyheter (DN), Sweden's largest morning newspaper.
Nurses and physicians have different views on DNR orders
Entering the room of a patient with cardiac arrest not knowing if there is a DNR order is something nurses don't want to experience. But this still happens. Ethical conflicts surroundings decisions not to resuscitate are common. Mona Pettersson spent 8 years researching DNR orders and in the process she interviewed both nurses and physicians.
Monitored by mom and dad
Jessica Nihlén Fahlquist, senior lecturer in biomedical ethics and researcher at Centre for Research Ethics & Bioethics, was interviewed for the Swedish Educational Broadcasting Company (Utbildningsradion, UR) about the ethics of parents monitoring their children via GPS.
What should we eat? New Swedish book on food and ethics
Anna T. Höglund, Associate Professor of Ethics, recently published a book in Swedish about food and ethics. According to her, asking the simple question "what should we eat?" raises questions relating to production and consumption of food. We are constantly reminded about the fact that the food we eat influences climate, how animals are taken care of, and the fact that what we eat has an influence on our health.
Research participants struggle to understand test results
Åsa Grauman, PhD student at the Centre for Research Ethics & Bioethics, asked people who participated in the large SCAPIS study how they perceived the test results they received after taking part in the project. They value the health screening, but identify shortcomings in the communication of test results.
Public awareness of antibiotic resistance
Antibiotic resistance is one of the biggest threats to global health, food security, and development today. Mirko Ancillotti's research focuses on the Swedish public's perception of this growing issue.
Should we be screening future parents for genetic disorders?
Should public health-care systems provide couples with expanded screening for genetic disorders before they decide to become pregnant? Screening programmes could increase our reproductive choices and autonomy. But there are ethical issues at stake.
HBP's Ethics Rapporteur Programme: Q&A with Manuel Guerrero
CRB’s Manuel Guerrero is task leader for the Human Brain Project’s Ethics Rapporteur Programme. Find out how this programme works to create communication links within the project to achieve and maintain the projects Responsible Research and Innovation goals.
Patients' perspectives on being included in medical product decision making
Including patient perspectives in medical product development and decision making is of increasing interest to patients themselves, physicians, authorities, and the pharmaceutical industry. Patient preference studies allows patients to influence decisions and drug development. CRB's Karin Schölin Bywall was interviewed on the subject by the Swedish Rheumatism Association.
Research - for better or for worse?
How do we ensure responsible research and research ethics? How do we minimize the risk of research results are used maliciously or fall into the wrong hands? And who is responsible for the results of research? The issue was discussed at FORMAS' breakfast seminar November 29th.
The complicated ethics of deciding not to resuscitate
If a patient is seriously ill, and would not be helped by CPR, there should be a well-documented decision not to resuscitate. But the decision is sometimes made too late, unclear, or not sufficiently communicated. And in the middle of this stands the nurse. Expected to quickly interpret the situation. In her thesis, Mona Pettersson describes the complicated ethics of DNR orders in hematolocy and oncology.
Including patients in decisions about drugs
Companies and authorities sometimes involve individual patients and patient representatives in their decisions. By using preference studies, we can find out what larger groups of patients think about drugs. And how they weigh the good and the bad against each other. But what do patients think about being included in these decisions?
Neuroscience of drug addiction highlights ethics and policy
A recently published paper on the neuroscience of drug addiction raises ethical and policy issues arising out of addiction. The paper concludes social and economic circumstances contribute towards the propensity of individuals to become addicted.
Deciding not to resuscitate: nurses’ and physicians’ perspectives
When deciding not to resuscitate patients in cardiac arrest, ethical issues arise. Nurses and physicians conflicting perspectives often cause frustration. In a new doctoral thesis from Uppsala University, Mona Pettersson examines clinical and ethical perspectives on “DNR orders” in cancer care.
Article on gene editing one of the most cited in European Journal of Human Genetics
A paper by CRB researcher Heidi C. Howard et al. on points and questions to consider for a responsible way forward for gene editing in humans is listed as one of the most cited and shared articles published in European Journal of Human Genetics between 2016-2017.
Biobank Sweden launches ELSI Helpdesk
The Swedish Research Council-funded research infrastructure Biobank Sweden supports healthcare providers and universities with medical faculties working towards national harmonization in biobanking.
Cancer patients receive inadequate information
Cancer patients looking for online information about experimental clinical drug trials risk finding that is not only bad, but sometimes also wrong. Also on official websites that aim to inform about available trials. According to a recently published study from Uppsala University, this can lead to consequences for patients.
Genetic risk: Should researchers let people know?
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants. However, the value of complex genetic risk information for individuals is uncertain. In a PhD thesis from Uppsala University, Jennifer Viberg Johansson suggests that this uncertainty needs to be acknowledged by both geneticists and ethicists.